Answers are grounded in this paper and cite their sources.
Recent discoveries have highlighted that small monovalent molecules can leverage a variety of cellular mechanisms to induce degradation of a specific target protein. This perspective exemplifies and contextualizes these mechanisms within drug discovery, with a focus on identification of novel monovalent degraders via cell-based high-throughput screening (HTS) methodologies. Considerations for screening strategies, assay technologies and mechanistic deconvolution are discussed, with emphasis on identification of degrader compounds from diverse compound collections.
No takes yet. Share an insight, caveat, or question.
Burston et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: